Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serologic evaluation of hepatitis B vaccination with Infanrix hexa
NL-OMON31015Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- May 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of pertussis filamentous haemagglutinin in hepatitis B (HBV), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Proportion with anti-HBs titer below protective threshold and Geometric mean anti-HBs titer. Started May 2009; status: active, not recruiting.
02
Drugs
pertussis filamentous haemagglutinin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON31015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31015.